Abstract
Subcutaneous allergen immunotherapy is a well-established treatment for allergic respiratory diseases. Once at maintenance doses, injections are typically given every 2 to 4 weeks and doses adjusted due to missed injections. During the Covid-19 pandemic our practice suspended immunotherapy injections from March 17, 2020 through May 5, 2020. Upon resumption, doses were adjusted with an emphasis on trying to keep patients in the same concentration vial as their previous injection. We sought to characterize reactions to restarting injections after prolonged disruption.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
